Is anyone else getting greedy about GOVX stock? I just read a report that the CEO has just increased his personal holding in the company. At the same time there are strong reports of monkeypox spreading from Africa to Europe. Fundamentally, I’m not sure that this company is a long-term play but it does seem like they’re in a good position to profit if there is a more significant push for a vaccination campaign from US or EU leaders. Not to mention that this company also has phase 2 trials for other vaccines going on, so I at least feel like they are a legitimate biotechnology firm. Plus, they’re trading under $10.00 so it’s not exactly a huge capital spend upfront, given their recent spikes.
Leave a Reply